Enhabit, Inc. (EHAB)
NYSE: EHAB · IEX Real-Time Price · USD
9.70
-0.20 (-2.02%)
May 8, 2024, 4:00 PM EDT - Market closed

Enhabit Market Cap

Enhabit has a market cap or net worth of $486.51 million as of May 8, 2024. Its market cap has decreased by -21.67% in one year.

Market Cap
486.51M
Enterprise Value
1.07B
1-Year Change
-21.67%
Ranking
Category
Stock Price
$9.70

Market Cap Chart

Since July 1, 2022, Enhabit's market cap has decreased from $1.13B to $486.51M, a decrease of -57.12%. That is a compound annual growth rate of -36.70%.

History

DateMarket Cap% Change
May 7, 2024496.50M0.40%
May 6, 2024494.50M-3.15%
May 3, 2024510.60M1.90%
May 2, 2024501.10M-1.86%
May 1, 2024510.60M0.89%
Apr 30, 2024506.10M-2.13%
Apr 29, 2024517.10M2.78%
Apr 26, 2024503.10M1.64%
Apr 25, 2024495.00M-2.96%
Apr 24, 2024510.10M-0.97%
Apr 23, 2024515.10M0.10%
Apr 22, 2024514.60M0.10%
Apr 19, 2024514.10M1.38%
Apr 18, 2024507.10M-0.49%
Apr 17, 2024509.60M-0.78%
Apr 16, 2024513.60M-1.82%
Apr 15, 2024523.10M0.29%
Apr 12, 2024521.60M-3.26%
Apr 11, 2024539.20M-1.73%
Apr 10, 2024548.70M-2.23%
Apr 9, 2024561.20M1.08%
Apr 8, 2024555.20M0.45%
Apr 5, 2024552.70M1.94%
Apr 4, 2024542.20M-1.63%
Apr 3, 2024551.20M3.38%
View and export this data all the way back to 2022. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
MaxCyte 501.17M
Alector 498.31M
LifeMD 489.84M
Jin Medical International 487.64M
Verve Therapeutics 481.51M
Allogene Therapeutics 474.61M
UroGen Pharma 474.03M
Fulcrum Therapeutics 472.99M
Market Cap Rankings